These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19234266)

  • 1. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
    Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
    AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
    Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
    J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between microbubble contrast-enhanced color doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results.
    Kitamura H; Kawasaki S; Nakajima K; Ota H
    J Clin Ultrasound; 2002 Oct; 30(8):465-71. PubMed ID: 12242734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
    Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
    Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
    Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.
    Lim JH; Choi D; Cho SK; Kim SH; Lee WJ; Lim HK; Park CK; Paik SW; Kim YI
    Radiology; 2001 Sep; 220(3):669-76. PubMed ID: 11526265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
    Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
    Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
    Kudo M; Hatanaka K; Inoue T; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
    Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
    Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
    AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Watai R; Pei Z; Kawasaki T; Minami Y; Chung H; Fukunaga T; Awai K; Maenishi O
    J Gastroenterol; 2005 Dec; 40(12):1139-47. PubMed ID: 16378178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.